Literature DB >> 20542250

Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus.

Dorothee Kretschmer1, Anne-Kathrin Gleske, Maren Rautenberg, Rong Wang, Martin Köberle, Erwin Bohn, Torsten Schöneberg, Marie-Joséphe Rabiet, Francois Boulay, Seymour J Klebanoff, Kok A van Kessel, Jos A van Strijp, Michael Otto, Andreas Peschel.   

Abstract

Virulence of emerging community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) and other highly pathogenic S. aureus strains depends on their production of phenol-soluble modulin (PSM) peptide toxins, which combine the capacities to attract and lyse neutrophils. The molecular basis of PSM-stimulated neutrophil recruitment has remained unclear. Here, we demonstrate that the human formyl peptide receptor 2 (FPR2/ALX), which has previously been implicated in control of endogenous inflammatory processes, senses PSMs at nanomolar concentrations and initiates proinflammatory neutrophil responses to CA-MRSA. Specific blocking of FPR2/ALX or deletion of PSM genes in CA-MRSA severely diminished neutrophil detection of CA-MRSA. Furthermore, a specific inhibitor of FPR2/ALX and of its functional mouse counterpart blocked PSM-mediated leukocyte infiltration in vivo in a mouse model. Thus, the innate immune system uses a distinct FPR2/ALX-dependent mechanism to specifically sense bacterial peptide toxins and detect highly virulent bacterial pathogens. FPR2/ALX represents an attractive target for new anti-infective or anti-inflammatory strategies. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20542250      PMCID: PMC3417054          DOI: 10.1016/j.chom.2010.05.012

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  43 in total

Review 1.  Formyl-peptide receptors revisited.

Authors:  Yingying Le; Philip M Murphy; Ji Ming Wang
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

2.  The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor.

Authors:  C Dahlgren; T Christophe; F Boulay; P N Madianos; M J Rabiet; A Karlsson
Journal:  Blood       Date:  2000-03-01       Impact factor: 22.113

Review 3.  Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease.

Authors:  Youhong Cui; Yingying Le; Hiroshi Yazawa; Wanghua Gong; Ji Ming Wang
Journal:  J Leukoc Biol       Date:  2002-10       Impact factor: 4.962

4.  N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor.

Authors:  Pieter-Jan Haas; Carla J C de Haas; Wendy Kleibeuker; Miriam J J G Poppelier; Kok P M van Kessel; John A W Kruijtzer; Rob M J Liskamp; Jos A G van Strijp
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

5.  Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA.

Authors:  Rong Wang; Kevin R Braughton; Dorothee Kretschmer; Thanh-Huy L Bach; Shu Y Queck; Min Li; Adam D Kennedy; David W Dorward; Seymour J Klebanoff; Andreas Peschel; Frank R DeLeo; Michael Otto
Journal:  Nat Med       Date:  2007-11-11       Impact factor: 53.440

6.  Synthesis and deformylation of Staphylococcus aureus delta-toxin are linked to tricarboxylic acid cycle activity.

Authors:  Greg A Somerville; Alan Cockayne; Manuela Dürr; Andreas Peschel; Michael Otto; James M Musser
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

7.  A truncated form of CKbeta8-1 is a potent agonist for human formyl peptide-receptor-like 1 receptor.

Authors:  Aram Elagoz; Duncan Henderson; Poda Suresh Babu; Sylvia Salter; Caroline Grahames; Lorna Bowers; Marie-Odile Roy; Patricia Laplante; Eric Grazzini; Sultan Ahmad; Paola M C Lembo
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

Review 8.  Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen.

Authors:  Battouli Saïd-Salim; Barun Mathema; Barry N Kreiswirth
Journal:  Infect Control Hosp Epidemiol       Date:  2003-06       Impact factor: 3.254

9.  Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.

Authors:  Carla J C de Haas; Karin Ellen Veldkamp; Andreas Peschel; Floor Weerkamp; Willem J B Van Wamel; Erik C J M Heezius; Miriam J J G Poppelier; Kok P M Van Kessel; Jos A G van Strijp
Journal:  J Exp Med       Date:  2004-03-01       Impact factor: 14.307

10.  Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor.

Authors:  Mauro Perretti; Nan Chiang; Mylinh La; Iolanda M Fierro; Stefano Marullo; Stephen J Getting; Egle Solito; Charles N Serhan
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  126 in total

1.  Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1.

Authors:  Andrei I Khlebnikov; Igor A Schepetkin; Liliya N Kirpotina; Lars Brive; Claes Dahlgren; Mark A Jutila; Mark T Quinn
Journal:  J Mol Model       Date:  2011-11-30       Impact factor: 1.810

Review 2.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

3.  Leukocidins and the Nuclease Nuc Prevent Neutrophil-Mediated Killing of Staphylococcus aureus Biofilms.

Authors:  Mohini Bhattacharya; Evelien T M Berends; Xuhui Zheng; Preston J Hill; Rita Chan; Victor J Torres; Daniel J Wozniak
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

Review 4.  Staphylococcal manipulation of host immune responses.

Authors:  Vilasack Thammavongsa; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Nat Rev Microbiol       Date:  2015-09       Impact factor: 60.633

5.  Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence.

Authors:  Maren Rautenberg; Hwang-Soo Joo; Michael Otto; Andreas Peschel
Journal:  FASEB J       Date:  2010-12-23       Impact factor: 5.191

6.  The virulence regulator Agr controls the staphylococcal capacity to activate human neutrophils via the formyl peptide receptor 2.

Authors:  Dorothee Kretschmer; Nele Nikola; Manuela Dürr; Michael Otto; Andreas Peschel
Journal:  J Innate Immun       Date:  2011-11-08       Impact factor: 7.349

Review 7.  The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

Review 8.  Mouse models for infectious diseases caused by Staphylococcus aureus.

Authors:  Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  J Immunol Methods       Date:  2014-04-24       Impact factor: 2.303

9.  Do amyloid structures formed by Staphylococcus aureus phenol-soluble modulins have a biological function?

Authors:  Yue Zheng; Hwang-Soo Joo; Vinod Nair; Katherine Y Le; Michael Otto
Journal:  Int J Med Microbiol       Date:  2017-09-01       Impact factor: 3.473

10.  CXCR1 Regulates Pulmonary Anti-Pseudomonas Host Defense.

Authors:  M Carevic; H Öz; K Fuchs; J Laval; C Schroth; N Frey; A Hector; T Bilich; M Haug; A Schmidt; S E Autenrieth; K Bucher; S Beer-Hammer; A Gaggar; M Kneilling; C Benarafa; J L Gao; P M Murphy; S Schwarz; B Moepps; D Hartl
Journal:  J Innate Immun       Date:  2016-03-08       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.